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Purpose: Respiratory impacts in pencil beam scanned proton therapy 
(PBS-PT) are accounted by extensive 4D dose calculations, where 
deformable image registration (DIR) is necessary for estimating de-
formation vector fields (DVFs). We aim here to evaluate the dosimetric 
errors induced by different DIR algorithms in their resulting 4D dose 
calculations by using ground truth(GT)-DVFs from 4DMRI.
Materials and methods: Six DIR methods: ANACONDA, Morfeus, 
B-splines, Demons, CT Deformable, and Total Variation, were respec-
tively applied to nine 4DCT-MRI liver data sets. The derived DVFs 
were then used as input for 4D dose calculation. The DIR induced 
dosimetric error was assessed by individually comparing the resultant 
4D dose distributions to those obtained with GT-DVFs. Both single-/
three-field plans and single/rescanned strategies were investigated. 
Results: Differences in 4D dose distributions among different DIR 
algorithms, and compared to the results using GT-DVFs, were pro-
nounced. Up to 40 % of clinically relevant dose calculation points 
showed dose differences of 10 % or more between the GT. Differences 
in V95(CTV) reached up to 11.34 ± 12.57 %. The dosimetric errors became 
in general less substantial when applying multiple-field plans or using 
rescanning. 
Conclusion: Intrinsic geometric errors by DIR can influence the clinical 
evaluation of liver 4D PBS-PT plans. We recommend the use of an 
error bar for correctly interpreting individual 4D dose distributions.
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INTRODUCTION
When treating moving targets in the thorax or abdomen 
with pencil beam scanned proton therapy (PBS-PT), due to 
the presence of breathing motion, a time-resolved 3D (4D) 
image is necessary for quantifying the motion characteristics 
and performing a 4D dose calculation. For treating this type 
of tumour with a highly precise technique such as PBS-PT, a 
4D dose calculation is crucial in order to take into account 
the deterioration of the dose distribution due to the relative 
motion between the target and the delivered pencil beams 
(interplay effects) [1–3]. 
To calculate motion induced geometric differences be-
tween two image phases, deformable image registration 
(DIR) is the standard approach for building up a point-
to-point correlation between corresponding features. To 
perform DIR, a fixed and a moving image are pre-defined 
to estimate the patient’s deformable motion between these 
two images [4]. The result of DIR is a deformation vector 
field (DVF), which contains vectors for each voxel pointing 
from the fixed image towards the moving image. 
For any form of radiotherapy, DIR is one of the irre-
placeable components for both inter- and intra- fractional 
dosimetric evaluation. It is especially important for PBS-PT, 
due to its high sensitivity to geometric accuracy. However, it 
is well known that DIR is an ill-posed problem intrinsically 
[5]. When applying different DIR methods to the same im-
age pair, the resulting motion estimations can be inaccurate 
and differ significantly from each other [6]. Some of these 
errors are quantifiable, and can be calculated by comparing 
the DIR estimated motion of well-defined landmarks to 
their actual positions in both images (the so-called ground 
truth (GT) data). This is the classic approach of evaluating 
any DIR algorithm performance, as used by many previous 
publications [7,8]. Despite compromising the efficiency 
for the error quantification, the more landmarks that are 
defined, the more reliable the results will be. In contrast, 


















































































the images, where the deformable problem is intrinsically 
ill-defined. Motion vectors in these regions will directly 
depend on the transformation model and regularization of 
the selected algorithm, and it is therefore unavoidable that 
ambiguity between different algorithms will exist. 
Any form of registration uncertainty can directly lead to 
distinguishable differences in dose distributions, which 
consequently influence any further dosimetric analysis and 
clinical decision-making [9]. In the literature, a number 
of studies have investigated the dosimetric uncertainties 
induced by a particular DIR method [10,11]. However, their 
conclusions were restricted to their selected DIR method, 
and a consensus on the clinical impact of DIR uncertainty 
is still difficult to achieve. Yeo et al. [12] compared calcu-
lated doses based on results from several available DIR 
algorithms with a measured dose using a deformable 3D 
dosimeter. However, DIR errors for real patient geometries 
may perform differently in contrast to the rather simple 
experimental setup used in that work. 
Zhang et al. [6] showed that the ambiguity of two DIR 
approaches can lead to significant differences in the esti-
mated motion maps, and subsequent 4D dose distributions, 
among liver cancer patients for PBS-PT, even if landmark 
registration errors were similar. Due to the lack of a compre-
hensive GT-DVF however, it is often impossible to validate 
the accuracy of DIR in the whole region of interest. 
In this work, we would like to improve the above studies 
in two aspects. First, to investigate the systematic errors in-
duced by DIRs in 4D dose calculations, using the unique ad-
vantage of comprehensive GT-DVFs extracted from synthetic 
4DCT-MRI [13]. Second, we include multiple DIR methods 
to reveal the extent of potential variation induced by differ-
ent algorithms. As such, six DIR methods (five commercially 
available and one research version) have been applied to nine 
4DCT-MRI data sets to estimate deformable motion within 
the abdomen region. Compared to previous works, we also 
consider comprehensive GT-DVFs as reference to quantify 
the absolute accuracy for deformable motion estimation. 
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Consequently, the resulting 4D dose distributions generated 
using different DIR algorithms can be directly compared 
under conditions of varying plan configurations, rescanning 
scenarios, patient geometries, and motion scenarios. 
MATERIALS AND METHODS
Synthetic 4DCT-MRI and ground truth deformation 
vector fields (GT-DVFs) 
4DCT-MRI data sets consist of end-of-exhalation 3DCTs 
(reference phases) modulated by consecutive and extended 
breathing motion extracted from 4DMRI data through a 
validated image processing method [13–15] (Fig. 1, upper 
left). Through this process, synthetic 4DCT-MRI data sets 
within the liver are obtained by warping the reference phase 
with DVFs extracted from 4DMRI using a combination of 
multiresolution affine registration and B-spline non-rigid 
registration [15].
Nine such 4DCT-MRI data sets, generated from motion 
artefact-free 3DCTs of three liver cancer patients (denoted 
as PI, PII, and PIII respectively), were included in this study. 
The reference phases of the three patients were modulated 
by three different 4DMRI motion scenarios indicated as 
motions A, B, and C [16]. Clinical target volumes (CTVs) at 
the reference phase were 122, 264, and 403 cm3 for patients 
I, II, and III respectively. Only 4DCT-MRI data sets corre-
sponding to the first breathing cycle were analysed, and no 
consideration of motion irregularity has been included in 
the study. For the nine data sets, the amplitude for the first 
breathing cycle (given by the mean of the amplitude of all 
different points within the whole liver region) of motion 
scenarios A, B, and C were 7.82 (SD = 2.01), 20.61 (SD = 3.39), 
and 16.88 (SD = 2.78) mm respectively. Additionally, motion 
periods (extracted using Fourier analysis) for this first cycle 
equalled 3.66, 4.62, and 7.22 s for A, B, and C respectively. 
The corresponding DVFs extracted from 4DMRI to generate 


















































































GT-DVFs. Subsequently, new DVFs were extracted from these 
nine 4DCT-MRI data sets using the different DIR methods 
being investigated (see Fig. 1). These GT-DVFs and DIR esti-
mated DVFs were used for the 4D dose calculation analysis. 
Deformable image registration (DIR) methods and 
derived deformation vector fields (DVFs)
Six DIR methods have been included in this study. DIR1 and 
DIR2 are available in the RayStation (RaySearch Laboratories, 
Stockholm, Sweden) treatment planning system used in the 
UMCG, whereas DIR3 and DIR4 [6] are algorithms provided 
in open source software (Plastimatch; www.plastimatch.com) 
and used at PSI. DIR5 and DIR6 were developed in turn by 
the commercial medical imaging software company Mirada 
Medical (Oxford, UK) and by the Computer Vision Labora-
tory in ETH Zurich (Zurich, Switzerland) respectively. The 
different DIR methods are based on the ANACONDA [17], 
Morfeus [18,19], B-splines, Demons, CT Deformable [20,21], 
and Total Variation [22] algorithm respectively (Suppl. 1). For 
each data set, all six approaches were applied to the reference 
phase as the fixed image. The remaining phases were defined 
as successive moving images (see Table S.1). 
4D dose calculation
The DVFs resulting from the application of the six DIR 
methods were used as input to the in-house 4D dose cal-
culation engine at PSI, which is an extension of the 3D 
dose calculation algorithm. The gantry (beam) coordinate 
system is defined as (s,t,u), in which s is the pencil beam 
central axis direction and (t0, u0) its position orthogonal to 
the field direction (Fig. 2(a)). The clinically used dose grid 
size in this coordinate system is 4 × 4 × 2.5 mm3. 
To extend the 3D dose calculation to a 4D dose calcula-
tion, time-dependent displacements of dose grid points for 
motions in the t and u directions are taken into account 
using displacement and density-variation maps derived 
from each phase of the relevant 4DCT-MRI data. The 4D 
dose calculation algorithm first estimates the time stamp 
51
of each delivered pencil beam [13]. The DIR extracted DVFs 
are then geometrically translated and rotated into the gantry 
(s,t,u) coordinate system, and sampled by the dose grid size 
to provide displacement maps for each dose grid point 
[6]. Density-variation maps are derived from the different 
4DCT-MRI phases using Siddon’s algorithm [23]. With these 
displacement and density-variation maps, the offsets of the 
dose grid points from their nominal positions are calculated 
and a 4D dose distribution obtained.
4D planning configurations
Static, single-field uniform dose (SFUD) plans [24] were cal-
culated on each of the reference phases of the three patients. 
Both single- and three-field plans were investigated. Field 
arrangements were anterior-posterior (F1), right lateral (F2), 
and anterior-inferior oblique (F3), with the three-field plan 
being a combination of all fields. 4D dose distributions for 
these were then subsequently obtained by using either the 
GT-DVFs or the DVFs resulting from the six DIR methods 
in the 4D dose calculation algorithm (Fig. 1). Single scan 
or five times layered rescanning [16] were simulated with 
the scanning parameters of Gantry 2 at PSI [25–27]. Plan 
delivery started at the reference phase of the corresponding 
4DCT-MRI. All analysed plan configurations and respective 
notations are given in Suppl. 2. 
Assessing DIR performance
The impact of using the different DVFs derived from the 
applied DIR methods in the 4D dose calculation has been 
assessed by (1) quantifying the geometric error in the beam 
coordinate system and (2) analysing dosimetric errors in the 
4D dose distribution. 
The DIR induced geometric error was quantified by the 
absolute differences of the derived DVFs from each DIR 
method with respect to the GT-DVFs (Suppl. 3). Since this 
study is focused on the impact of DIR on 4D dose distribu-
tions, the assessment of the geometric error was performed 


















































































within a defined field-specific volume of interest (fVOI) 
(Fig. 2(b)). To more precisely correlate the geometric error to 
the dosimetric error, we defined the fVOI as the dose region 
where the dose calculation grid covers patient geometry 
(to exclude dose regions outside the patient). As such, the 
geometric evaluation was performed only in regions that 
directly contribute to the 4D dose calculation. 
The 4D dose distributions obtained from the DVFs derived 
from the six DIRs were individually calculated and compared 
to those resulting when using the GT-DVFs. Both dose-vol-
ume histograms (DVHs) with error bands, as well as V95(CTV) 
values were analysed to quantify the impact of DIR in clinical 
practice. Difference DVHs (DDVHs), which correspond to 
the histograms of the absolute dose difference between the 
individual DIR estimated and GT 4D plans in an extension 
of the CTV volume (CTV + 1 cm), were computed. Finally, for 
each investigated DIR method, percentages of the extended 
CTV volume with absolute dose differences higher than 10 % 
were extracted from the DDVH for analysis.
RESULTS
DIR induced geometric error 
Geometric registration errors with respect to motion sce-
narios and DIR methods for all single-field arrangements 
are given in Table 1. The lowest and highest mean errors in 
the field direction for the smallest motion cases (motion 
scenario A) were achieved by DIR6 and DIR1 (0.72 ± 0.16 mm 
and 1.05 ± 0.29 mm respectively). Despite motion B having 
the highest amplitude within the liver (Suppl. 4.1), motion C 
actually showed larger movement in the different single- field 
directions within the selected fVOI. For motion C, all the 
errors increased up to 3.21 ± 0.54 mm for DIR3, 2.84 ± 0.52 mm 
for DIR1, and 2.22 ± 0.42 mm for DIR6. Overall, the best per-
formance was achieved by DIR6 for all three motion scenarios. 
Most importantly, it was also observed that all DIR methods 
underestimated the GT motion amplitudes (Table S.4.1).
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Fig. 1. Schematic representation of the workflow adopted in this 
paper.
Fig. 2. (a) Gantry (or beam) coordinate system defined by (s,t,u) 
represented in blue. (b) Anterior-posterior (F1) fVOI of patient 





























































































































































































































































































































































































DIR induced dosimetric error
Without rescanning, pronounced differences in 4D dose dis-
tributions were observed among the different DIR scenarios, 
and in comparison to the GT generated 4D dose distribu-
tions (Fig. 3(a)). Indeed, the impact of interplay was clearly 
different when using different DVFs as input to the 4D dose 
calculation. For the GT, DIR2, DIR4, DIR5, and DIR6 the 
effects of interplay were more pronounced than for the other 
two methods (DIR1 and DIR3), in which the dose distribu-
tions look more homogeneous. In fact, for this particular 
4D plan configuration, DVHs of the CTV and DDVHs of the 
extended CTV volume, obtained from the six DIR 4D plans, 
clearly differed from the GT DVH (Fig. 3(b.i) and (b.ii)), with 
all DIR plans underestimating the dose in-homogeneity due 
to the interplay effects in comparison to the GT plan. Addi-
tionally, substantial absolute V95(CTV) differences (between 
the GT and all investigated DIR methods) were observed 
(Fig. 4). For motion A, and single fields with single scans, 
V95(CTV) differences of 7.91 ± 3.46 % were observed for DIR3, 
and 2.02 ± 1.28 % for DIR2. Moderate motions in the fVOI 
(motion scenario B) and single fields without rescanning 
showed the greatest differences, with DIR3 and DIR2 having 
differences of 10.58 ± 14.08 % and 1.43 ± 1.37 % respectively. Of 
the six tested DIR methods, DIR2 achieved the lowest errors 
in V95(CTV) for most situations with the best prediction of 
interplay effects in comparison to the GT. 
Rescanning and/or multiple-field plans smoothed out 
the V95(CTV) differences for all three motion scenarios. For 
instance, for motion scenario B, three-field plans with res-
canning resulted in absolute V95(CTV) differences to the GT 
of 3.46 ± 1.40 % and 0.23 ± 0.19 % for DIR3 and DIR2 respec-
tively. For the smallest motion, negligible dosimetric errors 
were obtained for all DIR methods (0.37 ± 0.38 % for DIR3, 
0.30 ± 0.17 % for DIR2, and 0.24 ± 0.18 % for DIR4). V95(CTV) 
values for all 4D plan configurations can be found in Table 
S.4.2, showing that overestimation of target coverage is con-
sistent for the single-field single/rescanned, or multiple- field 
single scan DIR generated plans.
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Fig. 3. 4D dose calculation results for the example 4D plan con-
figuration of patient geometry PIII modulated by motion scenario 
C, and treated with the single anterior-posterior field F1 applied 
without any rescanning. This corresponds to the patient case with 
the largest tumour volume and moderate motion amplitude within 
the liver, but largest movement in the field direction within the 
selected fVOI. (a) 4D dose distributions using GT, DIR1, DIR2, DIR3, 
DIR4, DIR5, and DIR6 DVFs. The white normal and white dashed 
lines represent the CTV and CTV + 1 cm (extended CTV) delinea-
tions respectively. (b.i) CTV DVH and (b.ii) extended CTV DDVH 
curves obtained with the six DIR methods. The black solid line gives 
the DVH curve calculated with the GT. The red shadow represents 
the band obtained by using different motion estimation methods, 
and the solid red line is showing the mean value from the six DIRs.
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Fig. 4. Absolute differences 
between the V95(CTV) of a par-
ticular DIR method and the GT 
V95(CTV) for all analysed 4D plan 
configurations. These overall 
V95(CTV) errors are calculated by 
the mean ± D of the individual 
errors given by all three patient 
geometries combined, with 
respect to modulated motion 
scenario (a) A, (b) B, or (c) C, 
single- or three-field plans, and 
single scan or five times layered 
rescanning deliveries.
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Fig. 5. DDVH band between investigated DIR and GT in the ex-
tended CTV (CTV + 1cm) for all (a) single- vs. (b) three-field 4D 
plan configurations. Each individual plot gives the information for 
all motion scenarios (A, B, and C). The boxplots give the statistics 
of the volume of extended CTV with absolute dose differences 
higher than 10 %, with respect to DIR method used as input for 
the 4D dose calculation.
59
DDVH bands in the extended CTV for all 4D plan con-
figurations (as a function of DIR for each motion scenario 
(Fig. S.4.2.1 and Fig. S.4.2.2)) show that the accuracy of a 
particular DIR method does not depend just on the motion 
characteristics, or that any single DIR algorithm performed 
better for one particular motion scenario. Generally however, 
dose differences between DIR2 and the GT were the smallest 
for most of the 4D plan configurations and for all analysed 
motion scenarios. For the others, up to 40 % of the volume of 
extended CTV had absolute dose differences in comparison 
to the GT of more than 10 % for single-field plans delivered 
with a single scan (Fig. 5(a)). The largest dosimetric differ-
ences occurred for single-field plans delivered with a single 
scan for the largest motions (B and C). Dose differences using 
all DIRs could however be smoothed out when applying 
rescanning or adding fields to the treatment plan (Fig. 5(b)).
DISCUSSION
We have shown in this study that the application of different 
DIR methods to extract motion from 4D data sets can result 
in pronounced differences. Geometric differences of up to 
1.05 ± 0.29 mm for the smallest motion amplitude (motion A) 
and 3.21 ± 0.54 mm for larger motions (motion C) have been 
observed. Without motion mitigation, associated dosimetric 
differences in target coverage (assessed as differences in 
V95(CTV)) were as high as 7.91 ± 3.46 % for motion A and 
11.34 ± 12.57 % for motion B. Moreover, up to 40 % of the 
extended CTV volumes have been predicted to have abso-
lute dose differences in comparison to the GT dose of more 
than 10 %. However, differences in 4D dose distributions 
among different DIR scenarios, and compared to the GT, 
were significantly smoothed out in most cases when using 
multiple-field treatment plans and/or rescanning [26]. In 
addition, it was confirmed that larger motion amplitudes 
and deformations contribute to larger geometric registra-


















































































However, target coverage (quantified by the V95(CTV)) was 
highly dependent on other factors, such as magnitude of the 
interplay effects, and no linear relationship between target 
coverage and motion amplitude could be found. 
The 4D dose calculation algorithm selected for this project 
is the one developed at PSI. It obtains a 4D dose distribution 
by deforming the dose grid as a function of time, instead of 
performing multiple calculations of the dose on different 
3DCT phases, which need to be subsequently warped back 
to a reference phase for dose accumulation [28–30]. Thus, it 
has the potential advantage of allowing for a high number of 
recalculations in an acceptable time-frame. Additionally, un-
like the more standard 4D algorithm, the 4D dose calculation 
of PSI employs linear interpolation for the present motion 
between the phases of the 4D imaging and this approach 
has been shown to provide more accurate results [14,31,32].
Instead of focusing solely on the assessment of registra-
tion ambiguity as in the work performed by Zhang et al. [6], 
this study systematically investigates the performance of a 
variety of DIR algorithms, with respect to GT-DVFs, as part 
of a 4D dose calculation. Naturally, such GT-DVFs have also 
been extracted from 4DMRI using DIR and one could argue 
therefore, that DIR induced error is already present in these 
GT-DVFs. As such, these do not represent ’real’ GT anatomi-
cal motion, but rather an estimation that will depend on the 
characteristics of the extraction method used. Indeed, we 
cannot deny that DIR induced error is present in the GTs. 
However, these are treated as GTs for the 4DCT-MRI data 
set itself (where the different DIRs are applied), and not for 
the 4DMRI, and so these errors turn out to have minimal 
impact on our conclusions. Additionally, due to the much 
higher contrast in abdomen MRI images, we believe the 
DIR errors for the GTs are rather limited. Therefore, for 
DIR error assessment applications, the GT-DVFs used here 
as reference provide dense image features for comparison, 
being a great advantage over the common approach that 
relies on the sparse distribution of identifiable landmarks 
[7,8]. Moreover, the recently published American Association 
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of Physicists in Medicine task group 132 report provided 
recommendations for clinical DIR quality assurance, such 
as a digital phantom [32].
Although several 4D treatment plan configurations using 
SFUD have been analysed, further research still needs to 
be performed analysing 4D intensity-modulated proton 
therapy (IMPT) plan configurations. In addition, statistics 
could be improved by setting different starting phases for the 
treatment delivery, and only one breathing cycle has been 
considered, which in the 4D dose calculation was repeated, 
cycle-to-cycle, over the duration of the full delivery time per 
field. Results may vary even more if true, variable breathing 
patterns were taken into account. As such, the influence of 
irregular breathing patterns, as provided by the 4DCT-MRI 
approach, will be exploited in future work. 
Interestingly, the geometric and dosimetric accuracies pro-
vided by all tested DIR methods are not directly correlated. 
For most situations, Total Variation (DIR6) provided the 
lowest field-specific geometric errors and Morfeus (DIR2) 
the lowest dosimetric errors. However, it is important to 
remember the complex nature of 4D dose calculations, and 
so multiple other variables could have influenced this lack 
of correlation. Furthermore, DIR2 is the only algorithm that 
requires a contour of the liver to be delineated on all the 
registered image pairs, indicating that the addition of such 
anatomical information to the algorithm is a safe approach to 
improve accuracy. However, defining such regions of interest 
requires a considerable amount of manual work. Therefore, 
there should be careful consideration about which registra-
tion method to choose and whether the additional work is 
justified. As such, the choice of a slightly less accurate, but 
more time efficient, DIR method can have advantages as 
long as the uncertainties resulting from these approaches 
are understood. Indeed, we would recommend that, given 
the lack of accuracy demonstrated in this work between the 
different DIRs, it would make sense to provide error bars 
on dose calculations that depend on such algorithms. Such 


















































































calculations using different DIR algorithms for different 
treatment sites, as the one performed on this paper, which 
is specific for PBS-PT 4D dose calculations from liver cases.
In summary, to understand the influence of a particu-
lar registration algorithm on the 4D dose calculation, the 
accuracy of different DIR methods to estimate the GT re-
sults has been analysed. Regarding field-specific geometric 
registration error, it has been shown that all DIR methods 
underestimate motion amplitude in the fVOI for all applied 
fields. This consequently resulted in an overestimation of 
the calculated plan index of V95(CTV) for all DIR algorithms 
in comparison to the GT for most of the 4D plan configu-
rations analysed. The performance of this study is of great 
importance for the proton therapy community in general, 
and particularly for PBS-PT, due to its sensitivity to respira-
tory-induced impacts. As well for passively scattered proton 
therapy, or even conventional radiotherapy, where DIR is 
widely used for dose distribution warping and accumulation, 
we believe that our outcomes, especially on the DIR induced 
geometric error assessment, still remain noteworthy [33,34].
CONCLUSION 
The demonstrated dosimetric errors induced by different 
DIR methods indicate the necessity to interpret individual 
4D dose distributions for PBS-PT plans for liver cases with 
caution, and ideally with an error bar. However, by adding 
fields to the treatment plan and/or using motion mitigation 
techniques such as rescanning, the impact of DIR motion 
estimation uncertainties on the 4D dose distributions could 
be reduced. 
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Suppl. 1. Deformable image registration (DIR) methods 
The ANACONDA (Anatomically Constrained Deformation 
Algorithm) algorithm (DIR1) is a hybrid registration solution, 
in which the objective function includes both the intensity 
and geometric information of the images. The additional 
anatomical information needs to be provided by introducing 
contoured data sets. In RayStation, a region encompassing 
the liver was focused in order to achieve a higher accuracy 
in that targeted area. Morfeus (DIR2) is a set of algorithms 
for DIR, based on the biomechanical modelling of anatom-
ical structures. The biomechanical behaviour of soft tissue 
deformation is included in this method in order to improve 
accuracy and extensibility of the motion estimation. Despite 
not being an intensity-based approach, for lung applications, 
DIR2 already proved that it is able to efficiently model the 
biomechanics of respiration through the breathing motion, 
the sliding interface between the lungs and the chest cavity, 
and the nonlinearity of heterogeneous lung soft tissues. For 
the application of DIR1 and DIR2, the liver of the three 
patient cases were manually delineated in the reference 
3DCT using Mirada, and subsequently checked by an expe-
rienced physician. In DIR1, the manually countered liver 
was extended by 1 cm (excluding the rib cage), and then 
used as a focus region of interest (ROI) for the registration. 
In DIR2, a triangular surface mesh of liver for each of the 
nine 4DCT-MRI data sets was used as a controlling ROI for 
the registration. It is created by using DIR1 for warping the 
respective manually contoured livers to all the remaining 
phases of the first breathing cycle and latter correcting them. 
In DIR3 (B-splines algorithm), multi-resolution optimi-
zation is performed, so that a gradual refinement of the 
image resolution along with a gradual increase in the number 
of free transformation parameters (control points) can be 
achieved. DIR4 was implemented as symmetric log domain 
diffeomorphic Demons, initially by an affine transformation 
to obtain a global alignment. Moreover, the deformation 
67
field is smoothened by a Gaussian filter in order to avoid 
unrealistic deformation. Both DIR3 and DIR4 use CT image 
intensity itself as a similarity measurement. The mean square 
differences of intensity and the sum of squared differences, 
as an image similarity measure, were used respectively. The 
registration parameter settings for these two DIR algorithms 
have been extensively investigated in previous works for 
liver 4DCT registration. 
Mirada CT Deformable (DIR5) is a multi-resolution highly 
optimised derivative approach of the method of differences 
for handling large deformations and CT image artefacts in 
high speed. The method of differences iteratively uses the 
image intensity gradient, together with the intensity dif-
ferences between the images, to improve an initial estimate. 
DIR5 was applied by choosing a global approach (without any 
focus or controlling ROIs), and the setting super-fine was 
selected in order to obtain an optimal result.
ETH DIR (DIR6) uses an isotropic Total Variation regu-
larization that is able to estimate displacement fields that 
occur on both sides of sliding interfaces in the thorax and 
abdomen in 4D parametric image registration. Since organ 
sliding motion (non-smooth displacement fields) are han-
dled by this DIR method, no organ masks as input were used, 
and so a global approach was also selected for its application.
Table S.1 The six different DIR methods investigated in this paper, 
and the information regarding the addition of contoured structures 
in the images to the algorithm when applied.
DIR method Algorithm Additional geometry
DIR1 ANACONDA Focus ROI
DIR2 Morfeus Controlling ROIs
DIR3 B-splines None
DIR4 Demons None
DIR5 CT Deformable None


















































































Suppl. 2. 4D planning configurations
Table S.2 Configurations and respective notations of the static 
treatment plans.
An individual plan is denoted as P_F_S_M_E, where P 
represents the patient case (P ∈ {PI, PII, PIII}) and F stands 
for the number of fields (F ∈ {1FX, 3F}), where X represents 
the single-field orientation applied (X ∈ {1, 2, 3}). The re-
maining part of the plan denotation concern the 4D plans, 
where the scanning mode is given by S (S ∈ {single scan, five 
times layered rescanning}), M is the 4DMRI motion scenario 
(M ∈ {A, B, C}), and E stands for the used DVFs in the 4D dose 
calculation (E ∈ {GT, DIR1, DIR2, DIR3, DIR4, DIR5, DIR6}). 
The absolute dose difference between the plan obtained with 
the GT-DVFs (the GT 4D plan) and each one of the plans 
using the derived DVFs from the applied DIR methods (the 
DIR 4D plan) is denoted as P_F_S_M_DIR_diff, in which 
DIR ∈ {DIR1, DIR2, DIR3, DIR4, DIR5, DIR6}.



















Suppl. 3. Field-specific geometric error
The field-specific registration error was defined as the Eu-
clidean distance (eh,p,f)for each time phase h, patient geometry 
p and single field f, between the investigated DIR estimated 
position (tDIRh,p,f, uDIRh,p,f) and the GT position (tGTh,p,f, uGTh,p,f), 
calculated by (1). The geometric error of each of the six dif-
ferent DIR methods (error after DIR) was then quantified by 
eDIR. Conversely, the geometric error before the registration 
(eGTh,p,f) was the magnitude of the GT-DVFs in the machine 
coordinate system, given by (2).
  (1)
  (2)
and H belongs to the set of the image phases corresponding 
to the first breathing cycle of the 4DCT-MRI.
Suppl. 4. Results
Suppl. 4.1. DIR induced geometric error 
Motions in the gantry coordinate system were evaluated 
for one exemplary case (PIII, 1F1, motion scenario B). This 
choice for example configuration was made since larger 
motion amplitudes and deformations proved to be more 
difficult to predict with DIR, and so they tend to challenge 
the DIR performance more significantly. The overall sta-
tistics of the errors before and after the registration over 
all time phases (eGTp,f and eDIRp,f respectively) are shown 
in Fig. S.4.1 in form of boxplots (N = 822250). Several out-
liers (represented in black for GT and in colour for the six 
DIR methods) are present in the plots. The outliers of DIR1 
proved the largest errors, whilst DIR2 the lowest among all 
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phase ℎ, patient geometry 𝑝𝑝𝑝𝑝 and single field 𝑓𝑓𝑓𝑓, between the investigated DIR estimated position 
�𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓 ,𝑢𝑢𝑢𝑢𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓� and the GT position �𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓 ,𝑢𝑢𝑢𝑢𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓�, calculated by (1). The geometric 
error of each of the six different  metho s ( rror after DIR) was then quantified by 𝑒𝑒𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡. 
Conversely, the geometric error before the registration (𝑒𝑒𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓) was the magnitude of the GT-DVFs 
in the machine coordinate system, given by (2). 
 
𝑒𝑒𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓 = �(𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓2 − 𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓2 ) + (𝑢𝑢𝑢𝑢𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓2 − 𝑢𝑢𝑢𝑢𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓2 ), 
 




𝑒𝑒𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓 = �𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓2 + 𝑢𝑢𝑢𝑢𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓2 , 
 
𝑒𝑒𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓 =  �𝑒𝑒𝑒𝑒𝑡𝑡𝑡𝑡𝑡𝑡𝑡𝑡ℎ,𝑝𝑝𝑝𝑝,𝑓𝑓𝑓𝑓|h∈𝐻𝐻𝐻𝐻� 
 (2) 






























































































methods. The magnitude of estimated motion errors induced 
by DIR including outliers (with respect to the GT) were 
found to be as high as 32.59 mm (for DIR1), whilst no more 
than 19.67 mm for DIR2. The maximum and minimum me-
dian values (obtained with DIR2 and DIR6) were 1.41 mm and 
0.58 mm respectively. DIR3 and DIR6 showed the largest and 
lowest mean values (3.71 mm and 2.40 mm respectively). The 
25 %–75 % quartile for DIR (coloured boxes range) reached 
up to 2.82 mm for DIR6 and 6.01 mm for DIR3.
Fig. S.4.1. Motion error information for the GT and respective 
estimation from DIR in the gantry coordinate system over all phases 
of the first breathing cycle (eGTp,f and eDIRp,f) for the exemplary 
configuration (PIII, 1F1, motion scenario B).
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